LISATA THERAPEUTICS, INC. — Director's Dealing 2015

Feb 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2015-02-05

Reporting Person: VACZY CATHERINE M (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-05	Common Stock, $0.001 par value	A	30000	—	Acquired	79359	Direct
2015-02-05	Common Stock, $0.001 par value	F	12096	$3.54	Disposed	67263	Direct

Footnotes

F1: On February 5, 2015, the reporting person entered into an amendment to her employment agreement (the "Amendment") with NeoStem, Inc. (the "Company). Pursuant to the terms of the Amendment, the award consists of a grant of 30,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"). The award of Common Stock was made pursuant and subject to the terms and conditions of the Company's Amended and Restated 2009 Equity Compensation Plan (the "2009 Plan").